UK will use Gardasil in its HPV vaccination programme from next SeptemberBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d7694 (Published 25 November 2011) Cite this as: BMJ 2011;343:d7694
- Zosia Kmietowicz
From next September girls in the United Kingdom being vaccinated against human papillomavirus (HPV) will receive Gardasil, the vaccine that protects against genital warts as well as cervical cancer.
GlaxoSmithKline, which has been providing the Cervarix vaccine to the UK’s HPV vaccination programme since it launched in September 2008, said in a statement that it did not take part in the latest tendering exercise to provide a vaccine for the programme because the government made it clear that it wanted to protect girls against the types of HPV that caused cervical cancer and those that caused genital warts.
“GSK will not participate in tenders where the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial